Clinical trials
Recruiting Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
482 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 16 |
| 2023 | 27 |
| 2024 | 62 |
| 2025 | 142 |
| 2026 | 214 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 482 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 25 |
| Eli Lilly and Company | 21 |
| Hoffmann-La Roche | 6 |
| Johns Hopkins University | 6 |
| Pfizer | 6 |
| University of Kansas Medical Center | 6 |
| Amgen | 4 |
| AstraZeneca | 4 |
| Gan & Lee Pharmaceuticals. | 4 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 482 |
| Obesity | 448 |
| Diabetes Mellitus, Type 2 | 53 |
| Weight Loss | 44 |
| Insulin Resistance | 29 |
| Metabolic Syndrome | 21 |
| Prediabetic State | 21 |
| Diabetes Mellitus | 20 |
| Hypertension | 19 |
| Cardiovascular Diseases | 12 |
Trials
Showing 76 to 100 of 482. Each trial links to its page on Pharma Observatory.
382 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.